1. Introduction to Spot-Based Spatial Transcriptomics
Spot-based spatial transcriptomics represents a revolutionary leap forward in molecular biology, enabling researchers to map gene expression profiles directly onto histopathology slices. By using arrays of spatially barcoded primers printed on solid surfaces, this approach preserves the physical coordinates of mRNA molecules before they are processed for sequencing. This bridges the gap between traditional histology and high-throughput sequencing, allowing researchers to explore cellular heterogeneity within the structural context of tissues.
🧬 The Integration of Targeted Amplicon Sequencing
While whole-transcriptome spatial profiling offers a broad view of cellular gene expression, it often lacks the sequencing depth required to detect low-abundance transcripts, specific splice isoforms, or targeted mutations. Integrating targeted amplicon sequencing into spot-based spatial transcriptomics workflows addresses this challenge. By selectively amplifying specific transcripts of interest—such as tumor-associated genes, immune receptor sequences, or viral transcripts—researchers can achieve high sequencing depth and sensitivity at a fraction of the cost.
2. Mechanics of Spot-Based Spatial Amplicon Sequencing
The workflow begins with the placement of a cryopreserved or formalin-fixed paraffin-embedded (FFPE) tissue section onto a spatially barcoded slide. Each spot on the slide contains millions of capture probes, each sharing a unique spatial barcode. Following tissue permeabilization, target mRNAs diffuse and hybridize to these capture probes.
Instead of executing a universal reverse transcription and cDNA library preparation for the entire transcriptome, target-specific primers are introduced. These primers selectively target molecular amplicons of interest, such as:
- Highly Polymorphic Regions: Tracking clonal evolution in cancer tissues by targeting somatic mutations in oncogenes.
- Immune Receptor Repertoires: Identifying the spatial distribution of T-cell receptor (TCR) and B-cell receptor (BCR) clones in the tumor microenvironment.
- Pathogen Transcripts: Mapping the localization of viral or bacterial pathogens within host tissues during active infections.
Once reverse transcription is complete, the spatially barcoded cDNA molecules are pooled, PCR-amplified, and sequenced. Bioinformatics pipelines then map the sequenced amplicons back to their exact coordinate spots on the tissue slide, reconstructing a high-resolution, target-specific map of expression patterns.
Market Dynamics & Drivers
The global market for spatial biology is expanding rapidly, driven by the clinical demand for personalized medicine and targeted therapies. Pharmaceutical companies and academic laboratories are increasingly adopting spatial transcriptomics to identify biomarkers, understand drug resistance mechanisms, and map cellular microenvironments. However, the high cost of whole-transcriptome sequencing has historically limited its application in large-scale clinical trials and routine diagnostics.
Spot-based spatial amplicon sequencing addresses this limitation by offering a cost-effective, high-throughput alternative. By focusing sequencing power on targeted gene panels, clinical researchers can process hundreds of samples within a reasonable budget, accelerating the translation of spatial biology findings from the lab to the clinic.
Key Technological Trends
Several major trends are shaping the future of spatial amplicon sequencing:
- Increased Spot Resolution: Transitioning from 50µm spots to sub-micron features, enabling subcellular resolution of target amplicons.
- FFPE Compatibility: Optimization of chemical protocols to recover high-quality spatial amplicon data from archived clinical FFPE blocks.
- Multi-Omics Integration: Co-detecting protein biomarkers and targeted RNA amplicons on the same tissue section to gain a comprehensive understanding of biological processes.
- Automated Workflows: Implementing fully automated library preparation platforms to reduce hands-on time and minimize experimental variability.
Accelerate Your Spatial Research Projects
Get in touch with our spatial biology experts to design a targeted amplicon sequencing project tailored to your research goals.
Consult an Expert Now🩺 Oncology & Tumor Immunology
In oncology, understanding the spatial organization of the tumor microenvironment (TME) is critical. Spot-based spatial amplicon sequencing allows researchers to map somatic mutations, gene fusions, and immune checkpoint expression (e.g., PD-1, PD-L1) across different regions of a tumor. This helps identify how tumor cells interact with infiltrating immune cells and why certain regions develop resistance to immunotherapies.
🧠 Neurobiology & Diseases
The mammalian brain is highly structured, and its function relies on the precise spatial arrangement of diverse neuronal subtypes. By targeting specific neurotransmitter receptors and cell-type markers, spatial amplicon sequencing helps map cellular distributions in neurodegenerative diseases like Alzheimer's and Parkinson's, revealing localized pathological changes.
🌱 Plant Genomics & Pathology
Plant tissues present unique challenges due to cell walls and complex structures. Applying spatial amplicon sequencing allows researchers to study localized host-pathogen interactions, investigate developmental pathways in meristems, and analyze environmental stress responses at specific tissue layers without tissue dissociation.
Biomarker Technologies (BMKGene), founded in 2009, is a leading genomics service provider with over 16 years of continuous innovation in high-throughput sequencing and bioinformatics. Backed by more than 60 national invention patents and 200+ software copyrights, we deliver comprehensive multi-omics solutions—spanning genomics, metagenomics, epigenetics, single-cell omics, transcriptomics, and our proprietary BMKMANU S3000 spatial transcriptome technology—supported by our advanced BMKCloud bioinformatics platform. We have established long-term collaborations with organizations across 84 regions worldwide, providing reliable genomic solutions on a global scale.
Leading Multi-level Platforms
PacBio platforms: Sequel II, Sequel, RSII
Nanopore platforms: PromethION P48, GridION X5, MinION
10X Genomics: 10X ChromiumX, 10X Chromium Controller
Illumina platforms: NovaSeq
BGI-sequencing platforms: DNBSEQ-G400, DNBSEQ-T7
Additional Systems: Bionano Irys system, Waters XEVO G2-XS QTOF, QTRAP 6500+
Professional Automatic Molecular Lab
Spanning over 20,000 square feet, our facility houses state-of-the-art biomolecular laboratory instruments. We operate standardized laboratories for sample extraction, library construction, clean rooms, and sequencing labs. Every step, from sample extraction to sequencing, is performed under strict SOPs to ensure the highest data quality.
Reliable Bioinformatic Analysis
Powered by our self-developed BMKCloud platform, we offer flexible bioinformatics workflows. Our computing cluster features 4,260 computing cores with peak computing power over 121,708.8 Gflop per second, backed by CPUs with 41,104 memory and 3 PB total storage, ensuring rapid data turnaround.
Brilliant Lab 1000 (BL1000)
Biomarker Technologies (BMKGENE) and PerkinElmer have jointly built a fully automated experimental production line, called Brilliant Lab 1000 (BL1000), which is applied to the high-throughput NGS library construction service.
BMKGENE strives to greatly improve the entire line of sequencing products in terms of product types, production line throughput, delivery quality, and cycle time, to provide customers with better sequencing services.
Our commitment to quality is backed by international standards, collaborative joint laboratories, and rigorous academic credentials.
For inquiries about our products or pricelist, please leave your email to us.
We will be in touch within 24 hours.
Inquiry Now
